Burak Kürsad Günhan
Senior Principal Biostatistician
Merck Healthcare KGaA (Darmstadt, Germany)
I am a Senior Principal Biostatistician at Merck Healthcare KGaA (Darmstadt, Germany), where I work on early phase oncology trials. My work focuses on Bayesian methods, dose-escalation trials, and evidence synthesis, with a particular interest in developing practical statistical methods for clinical drug development. Previously, I received my PhD in biostatistics from the University Medical Center Göttingen.
See my resumé.
Interests
- Phase I dose-escalation trials
- Bayesian statistics
- Hierarchical models
- Network meta-analysis
Education
-
PhD in Biostatistics, 2020
University Medical Center Göttingen
-
MSc in Biostatistics, 2016
University of Zurich
-
BSc in Mathematics, 2012
Bogazici University (Istanbul)
Software
Statistical tools for Bayesian trial design and evidence synthesis
Publications
Selected methodological work in clinical trials and meta-analysis
Phase I dose-escalation oncology trials with sequential multiple schedules
A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules
Experience
Roles in biostatistics, methodology, and clinical development
Senior Principal Biostatistician
Merck Healthcare KGaA
Biostatistician (Intern)
Galapagos NV
Biostatistician (Intern)
Novartis Pharma AG
Research Associate
University Medical Center Göttingen
Responsibilities include:
- Methodological research in early clinical trials and meta-analysis
- Statistical programming
- Teaching
Biostatistician (Intern)
F. Hoffmann-La Roche AG
Talks
Conference talks and academic presentations
